We’re improving your experience!

×

Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.

Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.

Stay tuned for these updates, and thank you for being part of our community!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01391533
Title Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors
Acronym SARMET
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sanofi
Indications
Therapies
Age Groups: adult
Covered Countries USA | ITA | FRA | ESP

Facility Status City State Zip Country Details
Investigational Site Number 840001 Boston Massachusetts 02114 United States Details
Investigational Site Number 250002 Dijon 21079 France Details
Investigational Site Number 250001 Villejuif 94805 France Details
Investigational Site Number 380004 Bologna 40138 Italy Details
Investigational Site Number 380002 Milano 20133 Italy Details
Investigational Site Number 380001 Milano 20141 Italy Details
Investigational Site Number 724001 Barcelona 08035 Spain Details
Investigational Site Number 724003 Madrid 28040 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field